Effect of Linvemastat in Patients With Partially Controlled Asthma (syMMPonia)

Clinical trial NCT07191535 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07191535
Sponsor: Foresee Pharmaceuticals Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Asthma (Diagnosis)Pulmonary Function Moderate-to-Severe Asthma

Start date: 2027-03-01
Primary completion: 2028-01-01
Enrollment: 135

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.